Filing Details

Accession Number:
0001213900-14-009106
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-24 10:06:42
Reporting Period:
2014-12-22
Filing Date:
2014-12-24
Accepted Time:
2014-12-24 10:06:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
812796 Soligenix Inc. SNGX Pharmaceutical Preparations (2834) 411505029
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1068029 J Christopher Schaber 29 Emmons Drive, Suite C-10
Princeton NJ 08540
Chairman, Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-22 8,265 $1.21 75,761 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant Acquisiton 2014-12-24 4,959 $0.00 4,959 $1.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,959 2014-12-22 2019-12-22 No 4 P Direct